Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

Por: Los Angeles Times Science January 28, 2023

thumbnail

The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19. With new viral variants increasingly adept at defeating Evusheld, the FDA said the biological drug should no longer be used. The FDA decision marks the end — at least for now — of a medication that had helped... + full article



Similar News

Panel warns FDA’s beleaguered tobacco unit lacks direction

ABC News USA Health December 20, 2022

thumbnailWASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


Panel warns FDA’s beleaguered tobacco unit lacks direction

Associated Press USA Politics December 19, 2022

thumbnailWASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


FDA pauses US authorization for Eli Lilly's COVID treatment drug

Fox Business USA Business December 02, 2022

thumbnailFox News medical contributor Dr. Marty Makary discusses the 'unique set' of long COVID symptoms and explains why it's not likely to become the next public health disaster on 'Varney & Co.' The Food and Drug Administration announced on Wednesday that is... + más

Twitter was once a necessity for major brands. Under Elon Musk, it's now high risk. | CBS News

FDA pauses authorization for last remaining COVID-19 monoclonal antibody treatment | The Hill


Moderna to seek emergency authorization for COVID-19 vaccine use for kids under 6

New York Daily News USA Health October 10, 2022

thumbnailKids, prep those arms. Moderna announced Wednesday that it’s ready to ask the Food and Drug Administration for emergency authorization to begin administering the COVID-19 vaccine to children under 6 years old after testing a lower-dosage shot on about 6,700 participants. Two... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


ALS drug wins FDA approval despite questionable data

Associated Press USA Science September 30, 2022

thumbnailWASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News



About iurex | Privacy Policy | Disclaimer |